SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-03-033012
Filing Date
2003-10-09
Accepted
2003-10-09 14:27:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 a2120028zs-3.htm S-3 231434
3 EXHIBIT 5.1 a2120028zex-5_1.htm EX-5.1 5792
4 EXHIBIT 23.1 a2120028zex-23_1.htm EX-23.1 2059
5 EXHIBIT 23.3 a2120028zex-23_3.htm EX-23.3 2189
  Complete submission text file 0001047469-03-033012.txt   243364
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-109583 | Film No.: 03934834
SIC: 2835 In Vitro & In Vivo Diagnostic Substances